Browse Tag

merger

Salarius Pharmaceuticals (SLRX) Stock Jumps as $7M Offering Prices; Closing Expected November 12, 2025 Amid Decoy Therapeutics Merger

Salarius Pharmaceuticals (SLRX) Stock Jumps as $7M Offering Prices; Closing Expected November 12, 2025 Amid Decoy Therapeutics Merger

Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) is back in the headlines today after pricing a $7 million underwritten public offering tied to its pending business combination with Decoy Therapeutics. The company said the deal is expected to close “on or about November 12, 2025,” pending customary conditions, including consummation of the Decoy transaction. PR Newswire Key takeaways What happened today (Nov. 12, 2025) Salarius confirmed the pricing of its offering for gross proceeds of ~$7 million before fees. The package includes: The company notes the registration statement on Form S‑1 (File No. 333‑284368) became effective on Nov. 10, 2025, and the
Skyworks Soars 18% on $22B Qorvo Merger – What’s Next for the Chipmaker?

Skyworks Soars 18% on $22B Qorvo Merger – What’s Next for the Chipmaker?

Skyworks’ stock surge on Oct. 28 was driven almost entirely by the surprise merger announcement. In pre-market trading, shares spiked ~12% reuters.com, and by 9:48 a.m. ET the stock was around $89.22 (from about $75.84 Monday’s close) investing.com investing.com. This massive gap up reflects investor excitement: combined, Skyworks and Qorvo would control roughly $7.7 billion in annual RF-chip revenue (≈$5.1B mobile + $2.6B broadband) stocktitan.net, making a top U.S. analog/5G semiconductor supplier. The market welcomed the logic that scale and cross-selling should boost earnings – for example StockTitan notes the deal is “immediately accretive” to EPS and targets >$500M in yearly cost
AlphaVest (ATMV) Rockets on AMC Robotics Merger Buzz – Key Facts & Forecast

AlphaVest (ATMV) Rockets on AMC Robotics Merger Buzz – Key Facts & Forecast

SPAC Structure and Acquisition Target AlphaVest Acquisition Corp is a special-purpose acquisition company (SPAC) – a “blank check” issuer that raised capital through an IPO to merge with a private company stockanalysis.com globenewswire.com. It has no business operations of its own; its entire asset is cash held in a trust. SPAC shareholders typically get stock in the merged company or can redeem their shares for cash (the trust value) if the deal fails. AlphaVest’s announced target is AMC Corporation, a Washington-based technology company specializing in AI-driven security and safety solutions marketscreener.com. AMC has developed products like YI-brand smart cameras and
Strive’s Bitcoin Bonanza: $1.3B Merger, 11K BTC and a Wild Stock Ride

Strive’s Bitcoin Bonanza: $1.3B Merger, 11K BTC and a Wild Stock Ride

Overview of Strive and Its Role: Strive Asset Management began as an ETF issuer and anti-ESG investment firm (co-founded by Ramaswamy in 2022) etf.com globenewswire.com. In 2025 it transformed into a dedicated Bitcoin-treasury company. Strive’s business is to raise capital (through equity/debt) and convert it into Bitcoin holdings. The company uses a “preferred equity only” leverage model (no debt) to accumulate crypto globenewswire.com. By merger and acquisitions, Strive aims to become a large public company that simply hoards Bitcoin. Its own COO calls this building a “scaled, innovative and accretive Bitcoin acquisition platform” globenewswire.com. In practice, Strive is effectively a
Comerica’s Mega Merger Shock: Why CMA Stock Skyrocketed as Fifth Third’s $10.9 Billion Deal Reshaped Regional Banking

Comerica’s Mega Merger Shock: Why CMA Stock Skyrocketed as Fifth Third’s $10.9 Billion Deal Reshaped Regional Banking

Current Stock Performance & Market Reaction The announcement of Fifth Third Bancorp’s planned acquisition of Comerica sent CMA stock soaring. On 6 October 2025, Comerica’s investor‑relations website showed the stock opening near $81.00 and trading around $79.62–$80.56, up 9–14 % from the previous close investor.comerica.com. MarketWatch reported that CMA shares rallied 15.1 % to $81.20, a three‑year high, while Fifth Third’s shares dipped 0.3 % morningstar.com. The initial spike reflected the generous 20 % premium offered by Fifth Third and expectations that the combined bank would command more market share. Investors also reacted to a brighter regulatory outlook. Reuters noted that U.S. regulators have streamlined bank‑merger
Go toTop